Clinical Trials on 肺癌 NOS in Japan
总计2131个结果
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima Medical University; Kanagawa Cancer Center 和其他合作者未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Kyowa Kirin Co., Ltd.终止
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study Group主动,不招人
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Kyowa Kirin Co., Ltd.完全的
-
Kobe City General Hospital终止
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLC招聘中非小细胞肺癌 II 期 | 非小细胞肺癌 IB 期 | 非小细胞肺癌ⅢA期日本
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Kyowa Kirin Co., Ltd.完全的
-
Pfizer完全的系统性间变性大细胞淋巴瘤 | 非小细胞肺癌 ALK 阳性 | 非小细胞肺癌 c-Met 依赖 | 非小细胞肺癌 ROS 标志物阳性 | 除白血病外的晚期恶性肿瘤美国, 大韩民国, 澳大利亚, 日本
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan未知
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Gunma UniversityJ~pharma完全的
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完全的
-
Bristol-Myers Squibb完全的
-
Eisai Co., Ltd.完全的
-
Bristol-Myers SquibbOno Pharma USA Inc完全的
-
Astellas Pharma Global Development, Inc.终止
-
Daiichi Sankyo Co., Ltd.完全的
-
AstraZeneca完全的非小细胞肺癌 | 晚期实体瘤 | Neoplasms, | Metastatic Cancer,日本
-
Juntendo UniversityMerck Sharp & Dohme LLC主动,不招人
-
Eli Lilly and Company完全的
-
Eli Lilly and Company完全的
-
Shiga UniversityUniversity of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical University; Tohoku...未知
-
Pfizer完全的
-
Astellas Pharma Inc终止未接受过 EGFR-TKI 治疗且携带 EGFR 激活突变的 NSCLC 患者日本
-
Merck Sharp & Dohme LLC完全的